SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2bsx'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JDV_A_ADNA1260_1 (5'-METHYLTHIOADENOSI NE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 10	ARG A 88 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.44A	1jdvA-2bsxA: 31.9 1jdvD-2bsxA: 31.9	1jdvA-2bsxA: 29.30 1jdvD-2bsxA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JDV_B_ADNB2260_1 (5'-METHYLTHIOADENOSI NE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 10	ARG A 88 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.42A	1jdvB-2bsxA: 32.0 1jdvC-2bsxA: 31.8	1jdvB-2bsxA: 29.30 1jdvC-2bsxA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JDV_D_ADND3260_1 (5'-METHYLTHIOADENOSI NE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 10	ARG A 88 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.44A	1jdvA-2bsxA: 31.9 1jdvD-2bsxA: 31.9	1jdvA-2bsxA: 29.30 1jdvD-2bsxA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JDV_E_ADNE4260_1 (5'-METHYLTHIOADENOSI NE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 12	ARG A 88 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.41A	1jdvE-2bsxA: 31.9 1jdvF-2bsxA: 31.8	1jdvE-2bsxA: 29.30 1jdvF-2bsxA: 29.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ODI_A_ADNA1237_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 11	ARG A 88 GLY A 93 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.56A	1odiA-2bsxA: 25.0	1odiA-2bsxA: 27.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ODI_B_ADNB1237_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 11	ARG A 88 GLY A 93 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.53A	1odiB-2bsxA: 32.9	1odiB-2bsxA: 27.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ODI_C_ADNC1238_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 11	ARG A 88 GLY A 93 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.57A	1odiC-2bsxA: 33.4	1odiC-2bsxA: 27.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ODI_D_ADND1237_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 11	ARG A 88 GLY A 93 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.55A	1odiD-2bsxA: 33.3	1odiD-2bsxA: 27.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ODI_E_ADNE1237_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 11	ARG A 88 GLY A 93 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.53A	1odiE-2bsxA: 33.4	1odiE-2bsxA: 27.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ODI_F_ADNF1238_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 11	ARG A 88 GLY A 93 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.57A	1odiF-2bsxA: 33.3	1odiF-2bsxA: 27.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PK7_A_ADNA1245_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 9	ARG A 88 SER A 91 GLY A 93 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.54A	1pk7A-2bsxA: 32.0	1pk7A-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PK7_B_ADNB1246_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 8	ARG A 88 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.48A	1pk7B-2bsxA: 32.3	1pk7B-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PK7_C_ADNC1247_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 10	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.53A	1pk7C-2bsxA: 32.0	1pk7C-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PK7_C_ADNC1247_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 10	GLY A 93 VAL A 181 GLU A 182 MET A 183 ASP A 206	NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-4.1A)	1.35A	1pk7C-2bsxA: 32.0	1pk7C-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PK9_A_2FAA306_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 10	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.52A	1pk9A-2bsxA: 31.9	1pk9A-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PK9_B_2FAB307_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 9	ARG A 88 SER A 91 GLY A 93 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.49A	1pk9B-2bsxA: 32.2	1pk9B-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PK9_C_2FAC308_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 11	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.51A	1pk9C-2bsxA: 30.8	1pk9C-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PW7_A_RABA645_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 10	ARG A 88 SER A 91 GLY A 93 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.53A	1pw7A-2bsxA: 31.9	1pw7A-2bsxA: 28.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PW7_B_RABB646_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 9	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.53A	1pw7B-2bsxA: 32.2	1pw7B-2bsxA: 28.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PW7_C_RABC647_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 9	SER A 91 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 (-2.9A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.42A	1pw7C-2bsxA: 32.1	1pw7C-2bsxA: 28.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VHW_A_ADNA252_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 11	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.64A	1vhwA-2bsxA: 32.4 1vhwD-2bsxA: 32.5	1vhwA-2bsxA: 29.17 1vhwD-2bsxA: 29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VHW_B_ADNB252_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 9	ARG A 88 SER A 91 GLY A 93 VAL A 181 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.64A	1vhwB-2bsxA: 32.0 1vhwF-2bsxA: 32.2	1vhwB-2bsxA: 29.17 1vhwF-2bsxA: 29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VHW_C_ADNC252_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 11	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.63A	1vhwC-2bsxA: 32.6 1vhwE-2bsxA: 32.3	1vhwC-2bsxA: 29.17 1vhwE-2bsxA: 29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VHW_D_ADND252_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 11	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.62A	1vhwA-2bsxA: 32.4 1vhwD-2bsxA: 32.5	1vhwA-2bsxA: 29.17 1vhwD-2bsxA: 29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VHW_E_ADNE252_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 11	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.63A	1vhwC-2bsxA: 32.6 1vhwE-2bsxA: 32.3	1vhwC-2bsxA: 29.17 1vhwE-2bsxA: 29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VHW_F_ADNF252_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 10	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.64A	1vhwB-2bsxA: 32.0 1vhwF-2bsxA: 32.2	1vhwB-2bsxA: 29.17 1vhwF-2bsxA: 29.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1Z35_A_2FAA300_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 10	ARG A 88 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.63A	1z35A-2bsxA: 33.2	1z35A-2bsxA: 30.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1Z37_A_ADNA300_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 9	ARG A 88 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.59A	1z37A-2bsxA: 33.3	1z37A-2bsxA: 30.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AC7_A_ADNA1216_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 11	ARG A 88 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.56A	2ac7A-2bsxA: 31.7 2ac7B-2bsxA: 31.8	2ac7A-2bsxA: 29.71 2ac7B-2bsxA: 29.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AC7_B_ADNB1215_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 11	ARG A 88 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.56A	2ac7A-2bsxA: 31.7 2ac7B-2bsxA: 31.8	2ac7A-2bsxA: 29.71 2ac7B-2bsxA: 29.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J9C_A_ACTA1121_0 (HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	4 / 5	SER A 118 VAL A 190 SER A 68 VAL A 117	None	1.36A	2j9cA-2bsxA: undetectable 2j9cB-2bsxA: undetectable 2j9cC-2bsxA: 1.1	2j9cA-2bsxA: 19.92 2j9cB-2bsxA: 19.92 2j9cC-2bsxA: 19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_C_ACHC1210_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	4 / 8	ILE A 31 VAL A 33 TYR A 54 CYH A 52	None	1.01A	2xz5A-2bsxA: undetectable 2xz5C-2bsxA: undetectable	2xz5A-2bsxA: 22.22 2xz5C-2bsxA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_D_ACHD1210_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	4 / 8	ILE A 31 VAL A 33 TYR A 54 CYH A 52	None	1.00A	2xz5C-2bsxA: undetectable 2xz5D-2bsxA: undetectable	2xz5C-2bsxA: 22.22 2xz5D-2bsxA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_E_ACHE1210_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	4 / 7	ILE A 31 VAL A 33 TYR A 54 CYH A 52	None	1.01A	2xz5D-2bsxA: undetectable 2xz5E-2bsxA: undetectable	2xz5D-2bsxA: 22.22 2xz5E-2bsxA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_C_VIAC901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	4 / 7	HIS A 64 MET A 229 LEU A 138 VAL A 180	None	1.12A	3jwqC-2bsxA: undetectable	3jwqC-2bsxA: 21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T7V_A_SAMA992_0 (METHYLORNITHINE SYNTHASE PYLB)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 12	GLY A 65 GLY A 70 GLU A 77 LEU A 5 ALA A 42	None	1.21A	3t7vA-2bsxA: undetectable	3t7vA-2bsxA: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_A_ADNA251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 9	ARG A 88 SER A 91 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.74A	3u40A-2bsxA: 31.4 3u40F-2bsxA: 31.9	3u40A-2bsxA: 28.29 3u40F-2bsxA: 28.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_B_ADNB251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 10	ARG A 88 SER A 91 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.67A	3u40B-2bsxA: 31.1 3u40C-2bsxA: 31.9	3u40B-2bsxA: 28.29 3u40C-2bsxA: 28.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_C_ADNC251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 12	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.56A	3u40B-2bsxA: 31.1 3u40C-2bsxA: 31.9	3u40B-2bsxA: 28.29 3u40C-2bsxA: 28.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_D_ADND251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 11	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.55A	3u40D-2bsxA: 31.4 3u40E-2bsxA: 31.2	3u40D-2bsxA: 28.29 3u40E-2bsxA: 28.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_E_ADNE251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 12	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.51A	3u40D-2bsxA: 31.4 3u40E-2bsxA: 31.2	3u40D-2bsxA: 28.29 3u40E-2bsxA: 28.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_F_ADNF251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 10	ARG A 88 SER A 91 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.75A	3u40A-2bsxA: 31.4 3u40F-2bsxA: 31.9	3u40A-2bsxA: 28.29 3u40F-2bsxA: 28.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U40_F_ADNF251_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 10	VAL A 181 GLU A 182 MET A 183 GLU A 184 ASP A 206	NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A) NOS A1248 (-4.1A)	1.09A	3u40A-2bsxA: 31.4 3u40F-2bsxA: 31.9	3u40A-2bsxA: 28.29 3u40F-2bsxA: 28.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_E_CLME221_1 (CHLORAMPHENICOL ACETYLTRANSFERASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	3 / 3	PHE A 75 CYH A 71 HIS A 64	None	1.29A	3u9fF-2bsxA: undetectable	3u9fF-2bsxA: 18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_K_CLMK221_1 (CHLORAMPHENICOL ACETYLTRANSFERASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	3 / 3	PHE A 75 CYH A 71 HIS A 64	None	1.28A	3u9fL-2bsxA: undetectable	3u9fL-2bsxA: 18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UAW_A_ADNA236_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 11	ARG A 88 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.57A	3uawA-2bsxA: 32.3	3uawA-2bsxA: 29.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UAY_A_ADNA236_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 10	ARG A 88 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.55A	3uayA-2bsxA: 32.3	3uayA-2bsxA: 29.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AFG_C_QMRC1214_1 (CAPITELLA TELETA ACHBP)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	4 / 8	VAL A 33 TYR A 54 CYH A 52 ILE A 31	None	0.93A	4afgD-2bsxA: undetectable 4afgE-2bsxA: undetectable	4afgD-2bsxA: 21.62 4afgE-2bsxA: 21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4D9H_A_ADNA301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 11	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.55A	4d9hA-2bsxA: 31.7	4d9hA-2bsxA: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DA6_A_GA2A301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 9	SER A 91 GLY A 93 VAL A 181 MET A 183 GLU A 184	NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.48A	4da6A-2bsxA: 31.2	4da6A-2bsxA: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DA7_A_AC2A301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 10	ARG A 88 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.55A	4da7A-2bsxA: 31.3	4da7A-2bsxA: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DAN_A_2FAA301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 11	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.53A	4danA-2bsxA: 31.3	4danA-2bsxA: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DAN_B_2FAB301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	7 / 12	ARG A 88 SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.59A	4danA-2bsxA: 31.3 4danB-2bsxA: 31.4	4danA-2bsxA: 23.81 4danB-2bsxA: 23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L1W_B_STRB402_1 (ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	4 / 6	VAL A 134 VAL A 85 ILE A 86 LEU A 185	None	0.92A	4l1wB-2bsxA: undetectable	4l1wB-2bsxA: 21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N09_C_ADNC401_1 (ADENOSINE KINASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 12	LEU A 234 GLY A 90 ALA A 233 LEU A 20 GLY A 103	None	0.95A	4n09C-2bsxA: undetectable	4n09C-2bsxA: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RS0_A_IBPA706_1 (PROSTAGLANDIN G/H SYNTHASE 2)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 9	VAL A 21 LEU A 20 LEU A 78 GLY A 201 LEU A 188	None	1.07A	4rs0A-2bsxA: undetectable	4rs0A-2bsxA: 17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3C_A_AC2A301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 9	ARG A 88 SER A 91 GLY A 93 VAL A 181 MET A 183 GLU A 184	NOS A1248 ( 4.5A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.54A	5i3cA-2bsxA: 32.4	5i3cA-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3C_B_AC2B301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 10	SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.42A	5i3cB-2bsxA: 32.3	5i3cB-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I3C_C_AC2C301_1 (PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	6 / 11	SER A 91 GLY A 93 VAL A 181 GLU A 182 MET A 183 GLU A 184	NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-3.1A)	0.41A	5i3cC-2bsxA: 32.1	5i3cC-2bsxA: 28.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKR_B_ID8B602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 12	VAL A 21 LEU A 20 LEU A 78 GLY A 201 LEU A 188	None	1.07A	5ikrB-2bsxA: undetectable	5ikrB-2bsxA: 17.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZNC_A_QI9A301_0 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	5 / 9	VAL A 66 GLY A 93 VAL A 181 GLU A 182 ASP A 206	NOS A1248 ( 3.8A) NOS A1248 (-4.0A) NOS A1248 ( 4.4A) None NOS A1248 (-4.1A)	1.43A	5zncA-2bsxA: 42.8	5zncA-2bsxA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZNC_A_QI9A301_0 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	8 / 9	VAL A 66 SER A 91 GLY A 93 TYR A 160 VAL A 181 GLU A 182 MET A 183 TRP A 212	NOS A1248 ( 3.8A) NOS A1248 (-2.9A) NOS A1248 (-4.0A) NOS A1248 (-4.7A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) NOS A1248 (-4.6A)	0.31A	5zncA-2bsxA: 42.8	5zncA-2bsxA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZNI_A_YMZA302_0 (PURINE NUCLEOSIDE PHOSPHORYLASE)	2bsx	PURINE NUCLEOSIDE PHOSPHORYLASE (Plasmodium falciparum)	8 / 9	VAL A 66 GLY A 93 TYR A 160 VAL A 181 GLU A 182 MET A 183 GLY A 207 PRO A 209	NOS A1248 ( 3.8A) NOS A1248 (-4.0A) NOS A1248 (-4.7A) NOS A1248 ( 4.4A) None NOS A1248 (-3.4A) None NOS A1248 ( 4.1A)	0.46A	5zniA-2bsxA: 42.1	5zniA-2bsxA: 100.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1JDV_A_ADNA1260_1","5'-METHYLTHIOADENOSINE PHOSPHORYLASE;5'-METHYLTHIOADENOSINE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"ARG A  88;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.44A","1jdvA-2bsxA:31.9;1jdvD-2bsxA:31.9","1jdvA-2bsxA:29.30;1jdvD-2bsxA:29.30"],["1JDV_B_ADNB2260_1","5'-METHYLTHIOADENOSINE PHOSPHORYLASE;5'-METHYLTHIOADENOSINE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"ARG A  88;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.42A","1jdvB-2bsxA:32.0;1jdvC-2bsxA:31.8","1jdvB-2bsxA:29.30;1jdvC-2bsxA:29.30"],["1JDV_D_ADND3260_1","5'-METHYLTHIOADENOSINE PHOSPHORYLASE;5'-METHYLTHIOADENOSINE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"ARG A  88;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.44A","1jdvA-2bsxA:31.9;1jdvD-2bsxA:31.9","1jdvA-2bsxA:29.30;1jdvD-2bsxA:29.30"],["1JDV_E_ADNE4260_1","5'-METHYLTHIOADENOSINE PHOSPHORYLASE;5'-METHYLTHIOADENOSINE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.41A","1jdvE-2bsxA:31.9;1jdvF-2bsxA:31.8","1jdvE-2bsxA:29.30;1jdvF-2bsxA:29.30"],["1ODI_A_ADNA1237_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"ARG A  88;GLY A  93;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.56A","1odiA-2bsxA:25.0","1odiA-2bsxA:27.67"],["1ODI_B_ADNB1237_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"ARG A  88;GLY A  93;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.53A","1odiB-2bsxA:32.9","1odiB-2bsxA:27.67"],["1ODI_C_ADNC1238_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"ARG A  88;GLY A  93;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.57A","1odiC-2bsxA:33.4","1odiC-2bsxA:27.67"],["1ODI_D_ADND1237_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"ARG A  88;GLY A  93;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.55A","1odiD-2bsxA:33.3","1odiD-2bsxA:27.67"],["1ODI_E_ADNE1237_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"ARG A  88;GLY A  93;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.53A","1odiE-2bsxA:33.4","1odiE-2bsxA:27.67"],["1ODI_F_ADNF1238_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"ARG A  88;GLY A  93;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.57A","1odiF-2bsxA:33.3","1odiF-2bsxA:27.67"],["1PK7_A_ADNA1245_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;SER A  91;GLY A  93;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.54A","1pk7A-2bsxA:32.0","1pk7A-2bsxA:28.02"],["1PK7_B_ADNB1246_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.48A","1pk7B-2bsxA:32.3","1pk7B-2bsxA:28.02"],["1PK7_C_ADNC1247_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.53A","1pk7C-2bsxA:32.0","1pk7C-2bsxA:28.02"],["1PK7_C_ADNC1247_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"GLY A  93;VAL A 181;GLU A 182;MET A 183;ASP A 206","NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-4.1A)","1.35A","1pk7C-2bsxA:32.0","1pk7C-2bsxA:28.02"],["1PK9_A_2FAA306_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.52A","1pk9A-2bsxA:31.9","1pk9A-2bsxA:28.02"],["1PK9_B_2FAB307_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;SER A  91;GLY A  93;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.49A","1pk9B-2bsxA:32.2","1pk9B-2bsxA:28.02"],["1PK9_C_2FAC308_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.51A","1pk9C-2bsxA:30.8","1pk9C-2bsxA:28.02"],["1PW7_A_RABA645_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;SER A  91;GLY A  93;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.53A","1pw7A-2bsxA:31.9","1pw7A-2bsxA:28.35"],["1PW7_B_RABB646_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.53A","1pw7B-2bsxA:32.2","1pw7B-2bsxA:28.35"],["1PW7_C_RABC647_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"SER A  91;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 (-2.9A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.42A","1pw7C-2bsxA:32.1","1pw7C-2bsxA:28.35"],["1VHW_A_ADNA252_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.64A","1vhwA-2bsxA:32.4;1vhwD-2bsxA:32.5","1vhwA-2bsxA:29.17;1vhwD-2bsxA:29.17"],["1VHW_B_ADNB252_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;SER A  91;GLY A  93;VAL A 181;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.64A","1vhwB-2bsxA:32.0;1vhwF-2bsxA:32.2","1vhwB-2bsxA:29.17;1vhwF-2bsxA:29.17"],["1VHW_C_ADNC252_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.63A","1vhwC-2bsxA:32.6;1vhwE-2bsxA:32.3","1vhwC-2bsxA:29.17;1vhwE-2bsxA:29.17"],["1VHW_D_ADND252_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.62A","1vhwA-2bsxA:32.4;1vhwD-2bsxA:32.5","1vhwA-2bsxA:29.17;1vhwD-2bsxA:29.17"],["1VHW_E_ADNE252_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.63A","1vhwC-2bsxA:32.6;1vhwE-2bsxA:32.3","1vhwC-2bsxA:29.17;1vhwE-2bsxA:29.17"],["1VHW_F_ADNF252_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.64A","1vhwB-2bsxA:32.0;1vhwF-2bsxA:32.2","1vhwB-2bsxA:29.17;1vhwF-2bsxA:29.17"],["1Z35_A_2FAA300_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.63A","1z35A-2bsxA:33.2","1z35A-2bsxA:30.24"],["1Z37_A_ADNA300_1","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.59A","1z37A-2bsxA:33.3","1z37A-2bsxA:30.24"],["2AC7_A_ADNA1216_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.56A","2ac7A-2bsxA:31.7;2ac7B-2bsxA:31.8","2ac7A-2bsxA:29.71;2ac7B-2bsxA:29.71"],["2AC7_B_ADNB1215_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.56A","2ac7A-2bsxA:31.7;2ac7B-2bsxA:31.8","2ac7A-2bsxA:29.71;2ac7B-2bsxA:29.71"],["2J9C_A_ACTA1121_0","HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",4,"SER A 118;VAL A 190;SER A  68;VAL A 117","None","1.36A","2j9cA-2bsxA:undetectable;2j9cB-2bsxA:undetectable;2j9cC-2bsxA:1.1","2j9cA-2bsxA:19.92;2j9cB-2bsxA:19.92;2j9cC-2bsxA:19.92"],["2XZ5_C_ACHC1210_0","SOLUBLE ACETYLCHOLINE RECEPTOR","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",4,"ILE A  31;VAL A  33;TYR A  54;CYH A  52","None","1.01A","2xz5A-2bsxA:undetectable;2xz5C-2bsxA:undetectable","2xz5A-2bsxA:22.22;2xz5C-2bsxA:22.22"],["2XZ5_D_ACHD1210_0","SOLUBLE ACETYLCHOLINE RECEPTOR","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",4,"ILE A  31;VAL A  33;TYR A  54;CYH A  52","None","1.00A","2xz5C-2bsxA:undetectable;2xz5D-2bsxA:undetectable","2xz5C-2bsxA:22.22;2xz5D-2bsxA:22.22"],["2XZ5_E_ACHE1210_0","SOLUBLE ACETYLCHOLINE RECEPTOR","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",4,"ILE A  31;VAL A  33;TYR A  54;CYH A  52","None","1.01A","2xz5D-2bsxA:undetectable;2xz5E-2bsxA:undetectable","2xz5D-2bsxA:22.22;2xz5E-2bsxA:22.22"],["3JWQ_C_VIAC901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",4,"HIS A  64;MET A 229;LEU A 138;VAL A 180","None","1.12A","3jwqC-2bsxA:undetectable","3jwqC-2bsxA:21.93"],["3T7V_A_SAMA992_0","METHYLORNITHINE SYNTHASE PYLB","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"GLY A  65;GLY A  70;GLU A  77;LEU A   5;ALA A  42","None","1.21A","3t7vA-2bsxA:undetectable","3t7vA-2bsxA:22.32"],["3U40_A_ADNA251_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;SER A  91;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.74A","3u40A-2bsxA:31.4;3u40F-2bsxA:31.9","3u40A-2bsxA:28.29;3u40F-2bsxA:28.29"],["3U40_B_ADNB251_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;SER A  91;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.67A","3u40B-2bsxA:31.1;3u40C-2bsxA:31.9","3u40B-2bsxA:28.29;3u40C-2bsxA:28.29"],["3U40_C_ADNC251_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.56A","3u40B-2bsxA:31.1;3u40C-2bsxA:31.9","3u40B-2bsxA:28.29;3u40C-2bsxA:28.29"],["3U40_D_ADND251_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.55A","3u40D-2bsxA:31.4;3u40E-2bsxA:31.2","3u40D-2bsxA:28.29;3u40E-2bsxA:28.29"],["3U40_E_ADNE251_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.51A","3u40D-2bsxA:31.4;3u40E-2bsxA:31.2","3u40D-2bsxA:28.29;3u40E-2bsxA:28.29"],["3U40_F_ADNF251_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;SER A  91;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.75A","3u40A-2bsxA:31.4;3u40F-2bsxA:31.9","3u40A-2bsxA:28.29;3u40F-2bsxA:28.29"],["3U40_F_ADNF251_1","PURINE NUCLEOSIDE PHOSPHORYLASE;PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"VAL A 181;GLU A 182;MET A 183;GLU A 184;ASP A 206","NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A);NOS A1248 (-4.1A)","1.09A","3u40A-2bsxA:31.4;3u40F-2bsxA:31.9","3u40A-2bsxA:28.29;3u40F-2bsxA:28.29"],["3U9F_E_CLME221_1","CHLORAMPHENICOL ACETYLTRANSFERASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",3,"PHE A  75;CYH A  71;HIS A  64","None","1.29A","3u9fF-2bsxA:undetectable","3u9fF-2bsxA:18.39"],["3U9F_K_CLMK221_1","CHLORAMPHENICOL ACETYLTRANSFERASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",3,"PHE A  75;CYH A  71;HIS A  64","None","1.28A","3u9fL-2bsxA:undetectable","3u9fL-2bsxA:18.39"],["3UAW_A_ADNA236_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.57A","3uawA-2bsxA:32.3","3uawA-2bsxA:29.71"],["3UAY_A_ADNA236_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.55A","3uayA-2bsxA:32.3","3uayA-2bsxA:29.71"],["4AFG_C_QMRC1214_1","CAPITELLA TELETA ACHBP;CAPITELLA TELETA ACHBP;CAPITELLA TELETA ACHBP","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",4,"VAL A  33;TYR A  54;CYH A  52;ILE A  31","None","0.93A","4afgD-2bsxA:undetectable;4afgE-2bsxA:undetectable","4afgD-2bsxA:21.62;4afgE-2bsxA:21.62"],["4D9H_A_ADNA301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.55A","4d9hA-2bsxA:31.7","4d9hA-2bsxA:23.81"],["4DA6_A_GA2A301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"SER A  91;GLY A  93;VAL A 181;MET A 183;GLU A 184","NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.48A","4da6A-2bsxA:31.2","4da6A-2bsxA:23.81"],["4DA7_A_AC2A301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.55A","4da7A-2bsxA:31.3","4da7A-2bsxA:23.81"],["4DAN_A_2FAA301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.53A","4danA-2bsxA:31.3","4danA-2bsxA:23.81"],["4DAN_B_2FAB301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE;PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",7,"ARG A  88;SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.59A","4danA-2bsxA:31.3;4danB-2bsxA:31.4","4danA-2bsxA:23.81;4danB-2bsxA:23.81"],["4L1W_B_STRB402_1","ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",4,"VAL A 134;VAL A  85;ILE A  86;LEU A 185","None","0.92A","4l1wB-2bsxA:undetectable","4l1wB-2bsxA:21.08"],["4N09_C_ADNC401_1","ADENOSINE KINASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"LEU A 234;GLY A  90;ALA A 233;LEU A  20;GLY A 103","None","0.95A","4n09C-2bsxA:undetectable","4n09C-2bsxA:21.04"],["4RS0_A_IBPA706_1","PROSTAGLANDIN G\/H SYNTHASE 2","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"VAL A  21;LEU A  20;LEU A  78;GLY A 201;LEU A 188","None","1.07A","4rs0A-2bsxA:undetectable","4rs0A-2bsxA:17.52"],["5I3C_A_AC2A301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"ARG A  88;SER A  91;GLY A  93;VAL A 181;MET A 183;GLU A 184","NOS A1248 ( 4.5A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.54A","5i3cA-2bsxA:32.4","5i3cA-2bsxA:28.02"],["5I3C_B_AC2B301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.42A","5i3cB-2bsxA:32.3","5i3cB-2bsxA:28.02"],["5I3C_C_AC2C301_1","PURINE NUCLEOSIDE PHOSPHORYLASE DEOD-TYPE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",6,"SER A  91;GLY A  93;VAL A 181;GLU A 182;MET A 183;GLU A 184","NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-3.1A)","0.41A","5i3cC-2bsxA:32.1","5i3cC-2bsxA:28.02"],["5IKR_B_ID8B602_1","PROSTAGLANDIN G\/H SYNTHASE 2","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"VAL A  21;LEU A  20;LEU A  78;GLY A 201;LEU A 188","None","1.07A","5ikrB-2bsxA:undetectable","5ikrB-2bsxA:17.30"],["5ZNC_A_QI9A301_0","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",5,"VAL A  66;GLY A  93;VAL A 181;GLU A 182;ASP A 206","NOS A1248 ( 3.8A);NOS A1248 (-4.0A);NOS A1248 ( 4.4A);None;NOS A1248 (-4.1A)","1.43A","5zncA-2bsxA:42.8","5zncA-2bsxA:100.00"],["5ZNC_A_QI9A301_0","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",8,"VAL A  66;SER A  91;GLY A  93;TYR A 160;VAL A 181;GLU A 182;MET A 183;TRP A 212","NOS A1248 ( 3.8A);NOS A1248 (-2.9A);NOS A1248 (-4.0A);NOS A1248 (-4.7A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);NOS A1248 (-4.6A)","0.31A","5zncA-2bsxA:42.8","5zncA-2bsxA:100.00"],["5ZNI_A_YMZA302_0","PURINE NUCLEOSIDE PHOSPHORYLASE","2bsx","PURINE NUCLEOSIDE PHOSPHORYLASE","Plasmodium falciparum",8,"VAL A  66;GLY A  93;TYR A 160;VAL A 181;GLU A 182;MET A 183;GLY A 207;PRO A 209","NOS A1248 ( 3.8A);NOS A1248 (-4.0A);NOS A1248 (-4.7A);NOS A1248 ( 4.4A);None;NOS A1248 (-3.4A);None;NOS A1248 ( 4.1A)","0.46A","5zniA-2bsxA:42.1","5zniA-2bsxA:100.00"]]